Webinar Objectives: 

• The Eurotransplant Acceptable Mismatch Program
• How HLA epitope knowledge may benefit highly sensitized patients
• HLA-specific memory B cells: possible use for delisting and desensitization strategies
• Highly sensitized patients are disadvantaged by the presence of denatured HLA in Luminex HLA single antigen testing
• How implementing two SAB vendors can help patients

Speakers: Annette Jackson, Sebastiaan Heidt, Suzanne Bezstarosti, Gonca Karahan, Richard Battle, Alin Girnita 

Webinar Objectives: 

• The Genome Canada Consortium on Precision Medicine in Renal Transplantation
• The Evolution and Revolution in NGS
• Getting the basic building blocks rights- The impact of NGS based HLA typing on our clinical practice
• Definition of immunogenic and non-immunogenic HLA epitopes
• Updates from the HLA- DQ antibody component of the International Histocompatibility Workshop

Speakers: Paul Keown, Karen Sherwood, Sujatha Krisnakumar, Dolly Rose, Cynthia Kramer, Anat Tambur

Webinar Objectives: 

• What's in your toolbox? Experiences with LIFECODES ID assays
• What's in your toolbox? Experiences with LIFECODES LSA and C3d assays
• Non-HLA: A voyage into the unknown
• Clinical Relevance of Non-HLA Antibody Burden in Kidney Transplantation
• Non-HLA antibody panel: from bench to bedside

Speakers: Mike Gautreaux, Brett Loehmann, Bryan Ray, Alek Senev, Carrie Butler

Webinar Objectives:

• Blood component usage in the pre hospital setting
• The use of O positive red cells in the pre hospital setting

Speaker: Dr. James Raitt MBChB, FRCEM, FIMC, Kerry Dowling

Webinar Objectives: 

• Hematopoietic stem cell transplantation from unrelated donors in Germany
• Structures, Figures, Matching Guidelines, and Outcomes

Speaker: Dr. Joannis Mytilineos

Webinar Objectives: 

• HLA Matching Paradigms in Allogeneic HSCT

Speaker: Dr. Meenakshi Singh, Advanced center for Treatment, Research and Education in Cancer, Navi Mumbai, India

Webinar Objectives: 

• RhD Case Studies: Interpretation and Patient Risks in Transfusions
• Management of platelet alloimmunization on the Maternity Laboratory
• The challenging effects of monoclonal antibody therapies on the Transfusion Laboratory

Speakers: Dr Lilian Castilho, PhD, Dr Rachel Petermann, MD, PhD, Julie Staves Manager, Transfusion Laboratory

Webinar Objectives: 

• A breakthrough in ABO isoagglutinin titration automation: reason to believe & its benefits

Speakers: Dr. Soma Agrawal

Webinar Objectives:

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Seeing antibody detection through the lense of Sherlock Holmes

Speaker: Dawn M. Rumsey

Webinar Objectives: 

• Pathophysiology of thrombotic thrombocytopenic purpura (TTP)
• Laboratory characteristics of various ADAMTS13 tests
• Clinical applications of ADAMTS13 testing in diagnostics and management of patients with TTP

Speaker: Dong Chen MD PhD

Webinar Objectives:

• Advantages of Multi-Assay Analysis: Resolving Discrepancies between Solid Phase Immunoassays
• Non-HLA antibody panel discovery, development, and validation: From bench to bedside
• Redesigning HLA Compatibility: Does it work and are we ready?

Speaker: Julie Houp, MS CHS  Carrie L. Butler, Ph.D.  Massimo Mangiola, Ph.D. D(ACHI)

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Transplanting sensitized candidates: new options for overcoming DSA barriers

Speaker: Annette Jackson

Webinar Objectives: 

• Diagnosis of antibody-meditated rejection in 2021: antibodies, biopsies, and molecules

Speaker: Michael Mengel

Webinar Objectives: 

• Lab week Case Studies with Lifecodes LSA

Speaker: Dave Pinelli 

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives: 

• Overview of single antigen analysis technology
• Walk through of an interactive case study

Speakers: K. Kelly Cousins, Jean L. Heneghan

Webinar Objectives:

• Describe the relationship between Ren Blood cell antigens and their corresponding antibodies
• Learn about genes, antigens, and antibodies and how they are arranged in each system

Speaker: N/A

Webinar Objectives: 

• Review the Serologic Presentation
•  Discuss Adsorption Procedures
• How to differentiate WAIHA from Drug-Induced Hemolytic

Speaker: Sue Johnson MSTM, MT(ASCP)SBB

Webinar Objectives: 

• Discuss antibody development as part of the immune system
• Compare and contrast IgM and IgG class antibodies
• Examine reactivity of IgM and IgG class antibodies in common antibody detection methodologies
• Review publications on clinical significance of IgM and IgG class antibodies

Speaker: Tricia Sanders

Webinar Objectives: 

• Review Chronic Transfusion Therapy (CTT) for Sickle Cell Anemia (SCA)
• Present a prospective study of RBC genotyping of SCA patients and transfused units during CTT
• Clinical applications

Speaker: Marianne E. McPherson Yee, MD

Webinar Objectives: 

• Walk though case studies related to Immunohematology

Speaker: Rebacca Coward, MT (ASCP) SBB^CM

Webinar Objectives: 

• Geneotyping to resolve e-like Antibodies

Speaker: Dr. Shaun Lawicki, MBBS

Webinar Objectives: 

• Recognize serological testing results associated with monoclonal antibody therapy
• Identify when a patient is being treated with monoclonal antibody therapy based on what other drugs the patient is currently on
• Recognize monoclonal antibody therapy drugs that can interfere with serological testing

Speaker: Cynthia Ngo MLS (ASCP)^CM SBB^CM

Webinar Objectives: 

• Describe basic RHD genetics & biochemistry
• Discuss the complexity in the determining RhD antigen status in individuals with a serologic weak D phenotype
• List current recommendations from the participants of the AABB/CAP 2015 working party

Speaker: Sue Johnson MSTM, MT(ASCP)SBB

Webinar Objectives: 

• History of RH
• Nomenclature: Who is right, Who is wrong?
• Lack of RH Gene Expression
• RhD Negative Genotypes in Blacks
• Weak D Polymorphism
• Clinical Considerations for Partial D

Speaker: Joann Moulds, PhD

Webinar Objectives: 

• Identify the genetic mechanism for the inheritance of the ABH blood group antigen, including the Bombay phenotype
• Differentiate the transferases and biochemical structures of the ABH antigens
• Evaluate the characteristics of and relationship between antigens and antibodies in the ABO system
• Identify lectin reagents that show ABO blood groups specifically
• Assess the effects of disease and age on production of ABO antigens and antibodies
• Classify the A and B antigens into subgroups, including serologic characteristics, number of antigen site and frequency in the population

Speaker: LeeAnn Walker, MEd, MT(ASCP)SBB

Webinar Objectives:

• Discuss the purpose of antibody detection testing and techniques.
• Examine reagents used in antibody detection and crossmatch including potentiators and reagent red blood cells.
• Compare antibody detection testing to crossmatch testing

Speaker: Tricia Sanders

Webinar Objectives: 

• Explain the fundamental principles of evaluating reactivity in antibody identification studies
• Understand the differences in ruling-in antibodies (specifically conformation) and ruling-out antibodies (antibody exclusion)
• Perform uncomplicated antibody exclusions and comfirmation
• Discuss exceptions in and limitations of antibody exclusion rules

Speaker: Jan Hamilton MS,MT(ASCP)SBB

Webinar Objectives: 

• Compare and contrast the indirect antiglobulin test (IAT) and direct antiglobulin test (DAT)
• DAT reagents
• Possible causes of a positive DAT
• Elution types with application (Lui, Acid)

Speaker: Jay Slayten MS, MT(ASCP)SBB

Webinar Objectives: 

• Review the Rh proteins and Rh genes
• Review Rh terminology
• Illustrate the challenges of serologic Rh antigen typings and how molecular methods can help
• Discuss the AABB recommendations regarding use of RHD genotyping to resolve serologic weak D phenotype
• Use cases to illustrate how RHD genotyping can aid in determination of risk of alloimmunization
• Demonstrate how RH allele matching can be used to find compatible blood for a patient with an antibody to a high prevalence of RH antigen

Speaker: Margaret A. Keller, PhD.

Webinar Objectives: 

• Describe the process for collection of whole blood and apheresis components
• Describe the process for manufacturing components from whole blood
• Define the storage intervals for transfusable blood components
• Describe the process for perioperative blood salvage

Speaker: Heather Vaught, BS, MLS(ASCP)CM SBB

Webinar Objectives: 

• Review shared and unique antigen present on platelets
• Discuss antigen typing & antibody screening/identification
• Touch on disease-specific testing and management strategies

Speaker: Ralph R. Vassallo, MD, FACP

Webinar Objectives: 

• Discuss MNS, Kell, Lewis, Duffy and Kidd blood systems
• Discuss JK alleles that encode weak antigen expression

Speaker: Jill Storry, PhD

Webinar Objectives: 

• How Potentiators work
• IgM vs IgG antibodies
• Antibody Detection Test (IAT)
• Chemical treatment of Red Blood Cells
• W.A.R.M. ^TM  Immucor
• Column Agglutination Testing
• Solid Phase Red Cell Adherence
• The wide array of Potentiators: How to choose and apply

Speaker: Rebecca Coward MT(ASCP) SBB

Webinar Objectives: 

• Define solid phase technology
• Recall the steps for processing a capture Assay
• Interpret Capture results
• Identify the Capture products offered by Immucor

Webinar Objectives: 

• Define and categorize transfusion reactions
• Describe clinical manifestations of specific transfusion reactions
• Discuss patient evaluation and management when transfusion reactions is suspected

Speaker: Margo R Rollins, MD 

Webinar Objectives: 

• Define and categorize transfusion reactions
• Describe clinical manifestations of specific transfusion reactions
• Discuss patient evaluation and management when transfusion reactions is suspected

Speaker: Margo R Rollins, MD 

Webinar Objectives: 

• Hospitals and Blood Donar systems
• Blood Banks and Blood Transfusion
• Patient testing in Blood Banks
• Safe Blood Transfusion
• Blood Collection

Webinar Objectives: 

• Importance and significance in continuing education initiatives within the blood banking community

Speaker: Jay Slayten MS, MT(ASCP)SBB

Webinar Objectives: 

• What is and Red Blood Cell (RBC) and What is its importance
• RBC Critical Functions
• RBC Lifecycle and Membrane Structure
• Antigens on Membrane Surface

Webinar Objectives: 

• Describe the functions of enzymes on red blood cells
• Compare enzyme treatment to chemical treatment
• Discuss the use of enzyme treated red blood cells in antibody detection and identification pathways

Speaker: Tricia Sanders 

Webinar Objectives: 

• Discuss and interpret interactive immunohematology case studies

Speaker: Monica Kalvelage

Webinar Objectives:

• PICHE vs HLA
• Long- and Short-term effects
• How PIRCHE enhances antibody diagnostics
• PIRCHE walk through

Speaker: Matthias Niemann

Webinar Objectives: 

• Podcast style presentation with PIRCHE experts analyzing new frontiers in epitope matching

Speaker: Martha Deconinck  Matthias Niemann  Timothy Boadi​

Webinar Objectives: 

• Review the scope of BeadChip PreciseType^@ testing
• Discuss published indications for RBC genotyping in patients
• Describe Northwestern Memorial Hospital approach
• Examine benefits of DNA phenotyping in subsequent workups
• Discuss questions and comments

Speaker: Glenn Ramsey

Webinar Objectives: 

• Describe the application of molecular testing in the hospital donor center and transfusion service
• Discuss the impact of molecular testing on serologic antibody identification workups through case studies
• List the benefits of leveraging software to simultaniously view serology and molecular testing

Speakers: Jessie Singer MT (ASCP)  Cassandra Josephson MD

Webinar Objectives: 

• Define Monocyte Monolayer Assay (MMA) and determine when it should be considered
• Understand the role of molecular testing in the blood bank
• Evaluate the application of MMA and molecular testing using a case study approach

Speaker: Katrina Bilingsley